胆汁淤积性疲劳评估和治疗
曲颖, 陆伦根 . 胆汁淤积性疲劳评估和治疗[J]. 内科理论与实践, 2022 , 17(01) : 38 -42 . DOI: 10.16138/j.1673-6087.2022.01.007
| [1] | Phaw NA, Dyson JK, Mells G, et al. Understanding fatigue in primary biliary cholangitis[J]. Dig Dis Sci, 2021, 66(7): 2380-2386. |
| [2] | Liu Y, Tian S, Jia G, et al. Symptoms burden and health-related quality of life in Chinese patients with primary biliary cholangitis[J]. J Clin Transl Hepatol, 2021, 9(6): 860-867. |
| [3] | Marcus E, Stone P, Krooupa AM, et al. Quality of life in primary sclerosing cholangitis: a systematic review[J]. Health Qual Life Outcomes, 2021, 19(1): 100. |
| [4] | Dyson JK, Elsharkawy AM, Lamb CA, et al. Fatigue in primary sclerosing cholangitis is associated with sympathetic over-activity and increased cardiac output[J]. Liver Int, 2015, 35(5): 1633-1641. |
| [5] | Fricker ZP, Lichtenstein DR. Primary sclerosing cholangitis: a concise review of diagnosis and management[J]. Dig Dis Sci, 2019, 64(3): 632-642. |
| [6] | Jopson L, Dyson JK, Jones DE. Understanding and treating fatigue in primary biliary cirrhosis and primary sclerosing cholangitis[J]. Clin Liver Dis, 2016, 20(1): 131-142. |
| [7] | Jones DE, Bhala N, Burt J, et al. Four year follow up of fatigue in a geographically defined primary biliary cirrhosis patient cohort[J]. Gut, 2006, 55(4): 536-541. |
| [8] | Biagini MR, Tozzi A, Milani S, et al. Fatigue in primary biliary cirrhosis: a possible role of comorbidities[J]. Eur J Gastroenterol Hepatol, 2008, 20(2): 122-126. |
| [9] | Prince MI, James OF, Holland NP, et al. Validation of a fatigue impact score in primary biliary cirrhosis: towards a standard for clinical and trial use[J]. J Hepatol, 2000, 32(3): 368-373. |
| [10] | Jacoby A, Rannard A, Buck D, et al. Development, validation, and evaluation of the PBC-40, a disease specific health related quality of life measure for primary biliary cirrhosis[J]. Gut, 2005, 54(11): 1622-1629. |
| [11] | de Veer RC, da Silva G, van Hooff MC, et al. Measurement properties of the PBC-40 and PBC-27: a Dutch validation study[J]. BMJ Open Gastroenterol, 2021, 8(1): e000758. |
| [12] | Newton JL, Bhala N, Burt J, et al. Characterisation of the associations and impact of symptoms in primary biliary cirrhosis using a disease specific quality of life measure[J]. J Hepatol, 2006, 44(4): 776-783. |
| [13] | Newton JL, Elliott C, Frith J, et al. Functional capacity is significantly impaired in primary biliary cirrhosis and is related to orthostatic symptoms[J]. Eur J Gastroenterol Hepatol, 2011, 23(7): 566-572. |
| [14] | Mells GF, Pells G, Newton JL, et al. Impact of primary biliary cirrhosis on perceived quality of life: the UK-PBC national study[J]. Hepatology, 2013, 58(1): 273-283. |
| [15] | Newton JL, Hollingsworth KG, Taylor R, et al. Cognitive impairment in primary biliary cirrhosis: symptom impact and potential etiology[J]. Hepatology, 2008, 48(2): 541-549. |
| [16] | Mosher VAL, Swain MG, Pang JXQ, et al. Primary biliary cholangitis alters functional connections of the brain’s deep gray matter[J]. Clin Transl Gastroenterol, 2017, 8(7): e107. |
| [17] | Forton DM, Patel N, Prince M, et al. Fatigue and primary biliary cirrhosis: association of globus pallidus magnetisation transfer ratio measurements with fatigue severity and blood manganese levels[J]. Gut, 2004, 53(4): 587-592. |
| [18] | Swain MG, Jones DEJ. Fatigue in chronic liver disease: new insights and therapeutic approaches[J]. Liver Int, 2019, 39: 6-19. |
| [19] | Celik T, Gören MZ, Cinar K, et al. Fatigue of cholestasis and the serotoninergic neurotransmitter system in the rat[J]. Hepatology, 2005, 41(4): 731-737. |
| [20] | Nguyen H, Wang H, Le T, et al. Downregulated hypothalamic 5-HT3 receptor expression and enhanced 5-HT3 receptor antagonist-mediated improvement in fatigue-like behaviour in cholestatic rats[J]. Neurogastroenterol Motil, 2008, 20(3): 228-235. |
| [21] | Petrescu AD, Kain J, Liere V, et al. Hypothalamus-pituitary-adrenal dysfunction in cholestatic liver disease[J]. Front Endocrinol (Lausanne), 2018, 9: 660. |
| [22] | Burak KW, Le T, Swain MG. Increased sensitivity to the locomotor-activating effects of corticotropin-releasing hormone in cholestatic rats[J]. Gastroenterology, 2002, 122(3): 681-688. |
| [23] | Wanat MJ, Bonci A, Phillips PE. CRF acts in the midbrain to attenuate accumbens dopamine release to rewards but not their predictors[J]. Nat Neurosci, 2013, 16(4): 383-385. |
| [24] | Goldblatt J, James OF, Jones DE. Grip strength and subjective fatigue in patients with primary biliary cirrhosis[J]. JAMA, 2001, 285(17): 2196-2197. |
| [25] | Hollingsworth KG, Newton JL, Taylor R, et al. Pilot study of peripheral muscle function in primary biliary cirrhosis: potential implications for fatigue pathogenesis[J]. Clin Gastroenterol Hepatol, 2008, 6(9): 1041-1048. |
| [26] | Zhu H, Xu W, Wang N, et al. Anti-fatigue effect of Lepidium meyenii Walp. (Maca) on preventing mitochondria-mediated muscle damage and oxidative stress in vivo and vitro[J]. Food Funct, 2021, 12(7): 3132-3141. |
| [27] | Hardy T, MacDonald C, Jones DE, et al. A follow-up study of modafinil for the treatment of daytime somnolence and fatigue in primary biliary cirrhosis[J]. Liver Int, 2010, 30(10): 1551-1552. |
| [28] | Hollingsworth KG, Newton JL, Robinson L, et al. Loss of capacity to recover from acidosis in repeat exercise is strongly associated with fatigue in primary biliary cirrhosis[J]. J Hepatol, 2010, 53(1): 155-161. |
| [29] | Freer A, Williams F, Durman S, et al. Home-based exercise in patients with refractory fatigue associated with primary biliary cholangitis: a protocol for the EXerCise Intervention in cholesTatic LivEr Disease (EXCITED) feasibility trial[J]. BMJ Open Gastroenterol, 2021, 8(1): e000579. |
| [30] | Noureddin M, Sander-Struckmeier S, Mato JM. Early treatment efficacy of S-adenosylmethionine in patients with intrahepatic cholestasis[J]. World J Hepatol, 2020, 12(2): 46-63. |
| [31] | Lee JY, Danford CJ, Trivedi HD, et al. Treatment of fatigue in primary biliary cholangitis[J]. Dig Dis Sci, 2019, 64(8): 2338-2350. |
| [32] | Khanna A, Jopson L, Howel D, et al. Rituximab is ineffective for treatment of fatigue in primary biliary cholangitis[J]. Hepatology, 2019, 70(5): 1646-1657. |
| [33] | Almeida C, Choy EH, Hewlett S, et al. Biologic interventions for fatigue in rheumatoid arthritis[J]. Cochrane Database Syst Rev, 2016, 2016(6):CD008334. |
/
| 〈 |
|
〉 |
